ROCÍO
GARCÍA CARBONERO
Profesora asociada de Ciencias de la Salud
Teresa
Macarulla Mercadé
Teresa Macarulla Mercadé-rekin lankidetzan egindako argitalpenak (6)
2023
-
ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA
Genome Medicine, Vol. 15, Núm. 1
2022
-
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors
Journal for immunotherapy of cancer, Vol. 10, Núm. 3
2021
-
Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study
Annals of Oncology, Vol. 32, Núm. 5, pp. 600-608
-
Safety and activity of the TGFβ receptor i kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3
2019
-
TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer
Cancer Chemotherapy and Pharmacology
2018
-
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
British Journal of Cancer, Vol. 119, Núm. 10, pp. 1208-1214